Microbiome Therapeutics US is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Salvatore Morello
Senior Director, Global Regulatory Affairs at Janssen R & D


Sal Morello is a Senior Director in the Global Regulatory Immunology Department at Janssen R&D. Sal has 20 years of experience in regulatory affairs. He began his pharmaceutical career at SmithKline Beecham (now GlaxoSmithKline) as an analytical chemist, and held other positions in clinical research and regulatory affairs. He joined the regulatory team at Centocor (now Janssen R&D) in 2000. Sal has regulatory experience with biologics, drugs and devices, including live biotherapeutic products. He has worked in all phases of drug development and across multiple therapeutic areas including pulmonary, rheumatology, and gastroenterology. Sal has successfully filed major marketing applications. In his current role, he is responsible for developing and implementing global regulatory strategies for immunology compounds. He currently leads a cross-sector regulatory team focused on advancing microbiome-based products. Sal received his BS degree in Comprehensive Science from Villanova University and his MS degree in Quality Assurance/Regulatory Affairs from Temple University.

Salvatore Morello's Network

Agenda Sessions

  • Regulatory Challenges of Developing Microbiome based Live Biotherapeutic Products

    , 11:45am

Speakers at this event